Latest Stock Market News

Consolidated net profit rose to 201.6 million rupees ($2.42 million) for the quarter ended Sept. 30 from 167.2 million rupees a year earlier.

Derivative data showed that on the call side, the highest OI was observed at 19,500, followed by 19,600 strike prices, while on the put side, the highest OI was at 19,400 strike price.

The company said the cost of materials consumed was lower at Rs 2,634.92 crore in the second quarter of the ongoing fiscal as against Rs 3,101.56 crore in the year-ago period.

The stock quoted a 52-week high price of Rs 50449.9 and low of Rs 34968.6.

On November 7, Tuesday, StockEdge flagged 12 stocks with declining Relative Strength Index (RSI). In this article, we delve into RSI, a crucial indicator for traders and investors, and explore the implications of a falling RSI.

Revenue from operations during the reporting period increased 7% year-on-year to Rs 1,828 crore as against Rs 1702 crore a year ago. EBITDA or operating profit jumped 50% year-on-year to Rs 177 crore in the quarter, while margins improved to 9.7%.

The Nifty Pharma index closed 1.48 per cent up at 15497.25.

Sectorally, buying was seen in realty, oil & gas, healthcare and industrials while banks, telecom, IT and utilities saw some profit booking.

The footwear maker said its consolidated profit fell to 339.9 million rupees ($4.1 million) in the July-September quarter, from 548.2 million rupees in the year-ago quarter.